Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans

K Mahmoudi, A Bouras, D Bozec, R Ivkov… - International Journal …, 2018 - Taylor & Francis
Hyperthermia therapy (HT) is the exposure of a region of the body to elevated temperatures
to achieve a therapeutic effect. HT anticancer properties and its potential as a cancer …

Beyond the blood: brain barrier: the importance of central nervous system (CNS) pharmacokinetics for the treatment of CNS tumors, including diffuse intrinsic pontine …

KE Warren - Frontiers in oncology, 2018 - frontiersin.org
Over the past decade, we have made considerable progress in establishing diffuse intrinsic
pontine glioma (DIPG) as a disease entity and develo** preclinical tools to interrogate …

Convection-enhanced drug delivery for glioblastoma: A review

RS D'Amico, MK Aghi, MA Vogelbaum… - Journal of Neuro …, 2021 - Springer
Introduction Convection-enhanced delivery (CED) is a method of targeted, local drug
delivery to the central nervous system (CNS) that bypasses the blood-brain barrier (BBB) …

[HTML][HTML] Convection-enhanced delivery

AM Mehta, AM Sonabend, JN Bruce - Neurotherapeutics, 2017 - Elsevier
Convection-enhanced delivery (CED) is a promising technique that generates a pressure
gradient at the tip of an infusion catheter to deliver therapeutics directly through the …

Convection-enhanced delivery to the central nervous system

RR Lonser, M Sarntinoranont, PF Morrison… - Journal of …, 2015 - thejns.org
Convection-enhanced delivery (CED) is a bulk flow–driven process. Its properties permit
direct, homogeneous, targeted perfusion of CNS regions with putative therapeutics while …

Convection-enhanced delivery of nanocarriers for the treatment of brain tumors

E Allard, C Passirani, JP Benoit - Biomaterials, 2009 - Elsevier
Primary brain tumors have a significant infiltrative capacity as their reappearance after
resection usually occurs within 2cm of the tumor margin. Local delivery method such as …

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas

M Weaver, DW Laske - Journal of neuro-oncology, 2003 - Springer
The authors review the preclinical and clinical results of the ligand-targeted toxin conjugate
Transferrin-CRM107 (Tf-CRM107), for the treatment of malignant gliomas. Tf-CRM107 is a …

Non-invasive drug delivery across the blood–brain barrier: a prospective analysis

SK Niazi - Pharmaceutics, 2023 - mdpi.com
Non-invasive drug delivery across the blood–brain barrier (BBB) represents a significant
advancement in treating neurological diseases. The BBB is a tightly packed layer of …

Convection-enhanced delivery for the treatment of glioblastoma

MA Vogelbaum, MK Aghi - Neuro-oncology, 2015 - academic.oup.com
Effective treatment of glioblastoma (GBM) remains a formidable challenge. Survival rates
remain poor despite decades of clinical trials of conventional and novel, biologically …

Convection-enhanced delivery of therapeutics for brain disease, and its optimization

R Raghavan, ML Brady, MI Rodríguez-Ponce… - Neurosurgical …, 2006 - thejns.org
✓ Convection-enhanced delivery (CED) is the continuous injection under positive pressure
of a fluid containing a therapeutic agent. This technique was proposed and introduced by …